Glycosylation of ascites-derived exosomal CD133: a potential prognostic biomarker in patients with advanced pancreatic cancer.
Sakaue T, Koga H, Iwamoto H, Nakamura T, Ikezono Y, Abe M, Wada F, Masuda A, Tanaka T, Fukahori M, Ushijima T, Mihara Y, Naitou Y, Okabe Y, Kakuma T, Ohta K, Nakamura KI, Torimura T.
Sakaue T, et al. Among authors: fukahori m.
Med Mol Morphol. 2019 Dec;52(4):198-208. doi: 10.1007/s00795-019-00218-5. Epub 2019 Feb 25.
Med Mol Morphol. 2019.
PMID: 30805710
Clinical Trial.